Elisabetta Patorno, McGill University

Research

Bladder Cancer Drug Safety Population-Based Type 2 Diabetes

Latest funding

The comparative effectiveness and safety of four second-line antihyperglycemic drugs in type 2 diabetes mellitus: an international multi-centre cohort study
CIHR · 2021 · Supervisor
$100,000
Fracture risk of sodium-glucose co-transporter 2 inhibitor therapy in high-risk older adults: population-based studies to establish comparative safety
CIHR · 2020 · Supervisor
$100,000
SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study
CIHR · 2019 · Principal investigator
$286,875

The comparative effectiveness and safety of four second-line antihyperglycemic drugs in type 2 diabetes mellitus: an international multi-centre cohort study

SupervisorCIHR2021CIHR Fellowship

Principal investigators: Abrahami, Devin

Keywords: Cardiovascular Disease; Comparative Safety; Drug Safety; Pharmacoepidemiology; Real World Evidence; Type 2 Diabetes

$100,000

Fracture risk of sodium-glucose co-transporter 2 inhibitor therapy in high-risk older adults: population-based studies to establish comparative safety

SupervisorCIHR2020CIHR Fellowship

Principal investigators: Hayes, Kaleen N

Keywords: Aging; Bone Strength; Comparative Drug Safety; Diabetes Mellitus; Drug Safety; Fracture; Osteoporosis; Pharmacoepidemiology; Pharmacovigilance; Sodium-Glucose Transporter 2 Inhibitors

$100,000

SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study

Principal investigatorCIHR2019Project Grant

Principal investigators: Azoulay, Laurent; Patorno, Elisabetta

Keywords: Bladder Cancer; Drug Safety; Population-Based; Type 2 Diabetes

$286,875

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2019

Subject: Prospective PhD student: Bladder Cancer Dear Professor Patorno, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on bladder cancer connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study" (2019), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]